95 related articles for article (PubMed ID: 371798)
1. Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.
Johnsson JE; Tropé C; Mattsson W; Grundsell H; Aspegren K; Könyves I
Cancer Treat Rep; 1979 Mar; 63(3):421-4. PubMed ID: 371798
[TBL] [Abstract][Full Text] [Related]
2. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
Mittelman A; Catane R; Murphy GP
Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
[TBL] [Abstract][Full Text] [Related]
3. Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
Mattsson W; von Eyben F; Turesson I; Wählby S
Cancer; 1978 Jan; 41(1):112-6. PubMed ID: 342081
[TBL] [Abstract][Full Text] [Related]
4. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
5. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
Lutz D; Böhnel J
Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
[TBL] [Abstract][Full Text] [Related]
7. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
[TBL] [Abstract][Full Text] [Related]
8. [Prednimustine in treatment of acute leukemia in elderly patients].
Brandt L; Könyves I
Lakartidningen; 1977 Apr; 74(15):1490-3. PubMed ID: 321896
[No Abstract] [Full Text] [Related]
9. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L
Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481
[TBL] [Abstract][Full Text] [Related]
10. [A phase II study of prednimustine in advanced ovarian cancer].
Grundsell H; Johnsson JE; Tropé C
Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
[No Abstract] [Full Text] [Related]
11. Preliminary clinical study of prednimustine in lung cancer.
Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
J Med; 1977; 8(2):115-21. PubMed ID: 268397
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of spirogermanium in advanced ovarian malignancy.
Tropé C; Mattsson W; Gynning I; Johnsson JE; Sigurdsson K; Orbert B
Cancer Treat Rep; 1981; 65(1-2):119-20. PubMed ID: 6261944
[TBL] [Abstract][Full Text] [Related]
13. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD
Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925
[TBL] [Abstract][Full Text] [Related]
14. Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031).
Håkansson L; Könyves I; Lindberg LG; Möller T
Oncology; 1978; 35(3):103-6. PubMed ID: 673314
[TBL] [Abstract][Full Text] [Related]
15. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP
Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
17. Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
Chambers SK; Davis CA; Schwartz PE; Kohorn EI; Chambers JT
Clin Cancer Res; 1996 Oct; 2(10):1693-7. PubMed ID: 9816118
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
19. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
